Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-26 @ 4:05 AM
Study NCT ID:
NCT04934618
Status:
UNKNOWN
Last Update Posted:
2021-06-22
First Post:
2021-06-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase II Study of Carelizumab Combined With Irinotecan and Apatinib of Second-line Treatment for Advanced Gastric Cancer
Sponsor:
Nanfang Hospital, Southern Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-19
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05-19
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-12
First Submit QC Date:
None
Study First Post Date:
2021-06-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-20
Last Update Post Date:
2021-06-22
Last Update Post Date Type:
ACTUAL